Background: Survival analysis in clinical studies is important to assess th
e effectiveness of a given treatment and to understand the effect of variou
s disease characteristics. A number of methods exist to estimate the surviv
al rate and its standard error. However, one cannot be certain that these m
ethods have been handled appropriately. The widespread use of computers has
made it possible to carry out survival analysis without expert guidance, b
ut using inappropriate methods can give rise to erroneous conclusions. The
majority of the biomedical journals now recommend that a statistical review
of each manuscript should be carried out by an experienced bio-statisticia
n, in addition to obtaining expert referees' comments on the article. The p
roblem is compounded in papers from third-world countries where bio-statist
icians may not be available in all institutions to guide clinicians as to t
he selection of proper techniques,
Methods: The present paper deals with the various techniques of survival an
alysis and their interpretation, using a modal data set of malignant upper-
aerodigestive tract melanoma patients treated in the Regional Cancer Centre
, Trivandrum since 1982.
Results: The Kaplan-Meier method was found to be the most suitable for surv
ival analysis. The median survival time is a better method of summarizing d
ata than the mean. Rothman's method of estimation of the confidence limit i
s better than Peto's method as the confidence limit for survival probabilit
y tends to go beyond the range of 0-1.0 when calculated by Peto's method, e
specially when the sample size is small.
Conclusion: The results from the present study suggest that survival analys
is should be carried out by the Kaplan-Meier method. The median survival ti
me should be provided wherever possible, rather than relying on mean surviv
al. Confidence limits should be calculated as a measure of variability. A s
uitable rank test should be used to compare two or more survival curves, ra
ther than a Z-test. Stratified analysis and Cox's model, when stratified an
alysis fails, can be used to define the impact of prognostic factors on sur
vival.